Related Experiment Video
Updated: May 2, 2026
15:07
Real-time Digital Imaging of Leukocyte-endothelial Interaction in Ischemia-reperfusion Injury IRI of the Rat Cremaster Muscle
Published on: August 5, 2012
14.7K
C-reactive protein: clinical and epidemiological perspectives
Juan Salazar1, María Sofía Martínez1, Mervin Chávez1
1Endocrine-Metabolic Research Center, "Dr. Félix Gómez", Faculty of Medicine, University of Zulia, Maracaibo 4004, Zulia, Venezuela.
Cardiology Research and Practice
|March 22, 2014
Summary
C-reactive protein (CRP) is a key inflammation marker in atherosclerosis, a major cause of cardiovascular disease. Research explores its role as a cardiovascular risk predictor, potentially improving patient care and prevention strategies.
Area of Science:
- Cardiology
- Inflammation Biology
- Biomarker Research
Background:
- Atherosclerosis, a primary cause of cardiovascular disease, involves inflammation.
- C-reactive protein (CRP) is a well-established inflammation marker.
- The clinical utility of CRP in cardiovascular risk assessment is debated.
Purpose of the Study:
- To review the role of CRP in cardiovascular disease pathogenesis and risk prediction.
- To discuss the application of high-sensitivity CRP (hs-CRP) assays in clinical practice.
- To explore the integration of CRP into cardiovascular risk scoring systems.
Main Methods:
- Literature review of studies on CRP and cardiovascular disease.
- Analysis of high-sensitivity quantification methods for CRP.
- Examination of modified cardiovascular risk score systems incorporating CRP.
Main Results:
- CRP is implicated in the pathophysiology of atherosclerosis.
- High-sensitivity CRP assays (<1 mg/L) show promise for cardiovascular risk stratification.
- Modified risk scores including CRP may enhance prediction accuracy.
Conclusions:
- CRP is a significant molecule in cardiovascular disease research.
- hs-CRP holds potential as a valuable cardiovascular risk predictor.
- Incorporating CRP into risk scores could improve patient management for cardiovascular disease.
Related Concept Videos
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
765
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
765
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
1.3K
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K
01:19Pericarditis II: Clinical Features and Diagnostic Tests
633
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
633
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
943
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
943
01:30Coronary Artery Disease I: Introduction
1.8K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
01:27Psychoneuroimmunology: Cardiovascular Disease
757
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
757